NO20052730D0 - Aminoalkosyindoler som 5-HT6-reseptorligander for behandling av CNS-lidelser - Google Patents

Aminoalkosyindoler som 5-HT6-reseptorligander for behandling av CNS-lidelser

Info

Publication number: NO20052730D0
Authority: NO; Norway
Prior art keywords: aminoalkoxy; indoles; treatment; receptor ligands; cns disorders
Prior art date: 2002-12-03

Application number

NO20052730A

Other languages

English (en)

Other versions

NO20052730L (no

Inventor

Shu-Hai Zhao

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-12-03

Filing date

2005-06-07

Publication date

2005-06-07

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32469485&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20052730(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-06-07 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2005-06-07 Publication of NO20052730D0 publication Critical patent/NO20052730D0/no

2005-08-23 Publication of NO20052730L publication Critical patent/NO20052730L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Addiction (AREA)
Epidemiology (AREA)
Pain & Pain Management (AREA)
Psychology (AREA)
Child & Adolescent Psychology (AREA)
Diabetes (AREA)
Hematology (AREA)
Hospice & Palliative Care (AREA)
Nutrition Science (AREA)
Obesity (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Indole Compounds (AREA)
Steroid Compounds (AREA)

NO20052730A 2002-12-03 2005-06-07 Aminoalkosyindoler som 5-HT6-reseptorligander for behandling av CNS-lidelser NO20052730L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US43050602P	2002-12-03	2002-12-03
PCT/EP2003/013372 WO2004050085A1 (en)	2002-12-03	2003-11-27	Aminoalkoxyindoles as 5-ht6-receptor ligands for the treatment of cns-disorders

Publications (2)

Publication Number	Publication Date
NO20052730D0 true NO20052730D0 (no)	2005-06-07
NO20052730L NO20052730L (no)	2005-08-23

Family

ID=32469485

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20052730A NO20052730L (no)	2002-12-03	2005-06-07	Aminoalkosyindoler som 5-HT6-reseptorligander for behandling av CNS-lidelser

Country Status (24)

Country	Link
US (1)	US7084169B2 (no)
EP (1)	EP1569638B1 (no)
JP (1)	JP4339795B2 (no)
KR (1)	KR100755580B1 (no)
CN (1)	CN1713908B (no)
AR (1)	AR042155A1 (no)
AT (1)	ATE372113T1 (no)
AU (1)	AU2003289903B2 (no)
BR (1)	BR0316962A (no)
CA (1)	CA2508315A1 (no)
DE (1)	DE60316180T2 (no)
ES (1)	ES2291722T3 (no)
HR (1)	HRP20050457A2 (no)
MX (1)	MXPA05005790A (no)
MY (1)	MY138466A (no)
NO (1)	NO20052730L (no)
NZ (1)	NZ539950A (no)
PA (1)	PA8589801A1 (no)
PE (1)	PE20040763A1 (no)
PL (1)	PL377464A1 (no)
RU (1)	RU2350602C2 (no)
TW (1)	TWI284124B (no)
WO (1)	WO2004050085A1 (no)
ZA (1)	ZA200504412B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5417142A (en) *	1992-12-18	1995-05-23	Caterpillar Inc.	Hydraulic amplifier
PT1956004E (pt)	2002-03-27	2012-08-31	Glaxo Group Ltd	Derivados de quinolina e sua utilização como ligandos 5-ht6
PL1558582T3 (pl)	2003-07-22	2006-05-31	Arena Pharm Inc	Diarylowe i aryloheteroarylowe pochodne mocznika jako modulatory receptora serotoninowego 5-HT2A użyteczne w profilaktyce i w leczeniu zaburzeń związanych z tym receptorem
GB0500604D0 (en) *	2005-01-13	2005-02-16	Astrazeneca Ab	Novel process
US20090221644A1 (en) *	2005-06-30	2009-09-03	Stuart Edward Bradley	Gpcr Agonists
CN101282938A (zh) *	2005-08-15	2008-10-08	惠氏公司	作为5-羟色胺-6配体的经取代3-磺酰基吲唑衍生物
MX2008009022A (es) *	2006-01-13	2008-09-24	Wyeth Corp	1h-indoles sustituidos por sulfonilo como ligandos para los receptores 5-hidroxitriptamina.
MX2008013053A (es) *	2006-04-12	2008-10-17	Wyeth Corp	Derivados de dihidri[1,4]oxazino[2,3,4-hi]indazol-sustituidos como ligandos de 5-hidroxitriptamina-6.
US20100041672A1 (en) *	2007-03-21	2010-02-18	Glaxo Group Limited	Use of quinoline derivatives in the treatment of pain and irritable bowel syndrome
US9084742B2 (en)	2007-12-12	2015-07-21	Axovant Sciences Ltd.	Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-Quinoline
WO2009123714A2 (en)	2008-04-02	2009-10-08	Arena Pharmaceuticals, Inc.	Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
WO2010062321A1 (en)	2008-10-28	2010-06-03	Arena Pharmaceuticals, Inc.	Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto
CN102558020B (zh) *	2011-12-12	2013-09-18	温州大学	一种3-芳巯基吲哚类化合物的合成方法
CN103288707B (zh) *	2013-05-28	2015-12-23	浙江大学	一种3-苯巯基吲哚衍生物的制备方法
JP6515175B2 (ja)	2014-07-08	2019-05-15	サンシャイン・レイク・ファーマ・カンパニー・リミテッドＳｕｎｓｈｉｎｅＬａｋｅＰｈａｒｍａＣｏ．，Ｌｔｄ．	芳香族ヘテロ環誘導体及びその医薬的適用
MX388281B (es)	2015-06-12	2025-03-11	Axovant Sciences Gmbh	Derivados de diaril y arilheteroaril urea como moduladores del receptor 5ht2a de serotonina útiles para la profilaxis y el tratamiento de un trastorno conductual del sueño rem.
CA2992518A1 (en)	2015-07-15	2017-01-19	Axovant Sciences Gmbh	Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of hallucinations associated with a neurodegenerative disease

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1139760A (en)	1979-03-07	1983-01-18	Makiko Sakai	1,4-dioxaspiro¬4,5\| decene compounds
FR2589863B1 (fr)	1985-11-12	1988-07-29	Sanofi Sa	Derives d'hydroxy-4 indole, leur procede de preparation et leur utilisation
US5254595A (en)	1988-12-23	1993-10-19	Elf Sanofi	Aryloxypropanolaminotetralins, a process for their preparation and pharmaceutical compositions containing them
US4939138A (en) *	1988-12-29	1990-07-03	Sterling Drug Inc.	2- and 3-aminomethyl-6-arylcarbonyl-2,3-dihydropyrrolo(1,2,3-DE)-1,4-benzoxazines
GB9125900D0 (en) *	1991-12-05	1992-02-05	Wyeth John & Brother Ltd	Piperazine derivatives
FR2740686B1 (fr)	1995-11-03	1998-01-16	Sanofi Sa	Formulation pharmaceutique lyophilisee stable
AU4091697A (en) *	1996-08-27	1998-03-19	American Home Products Corporation	4-aminoethoxy indoles as dopamin d2 agonists and as 5ht1a ligands
GB9902452D0 (en)	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
FR2791344B1 (fr)	1999-03-25	2002-02-15	Adir	Nouveaux derives dimeriques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2793793B1 (fr)	1999-05-19	2004-02-27	Adir	Nouveaux derives dimeriques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
TWI222450B (en) *	1999-07-28	2004-10-21	Upjohn Co	Oxazinocarbazoles for the treatment of CNS diseases
TW593278B (en) *	2001-01-23	2004-06-21	Wyeth Corp	1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
EP1392682A2 (en) *	2001-04-20	2004-03-03	Wyeth	Heterocyclylalkoxy-, -alkylthio- and -alkylaminobenzazole derivatives as 5-hydroxytryptamine-6 ligands

2003
- 2003-11-27 TW TW092133339A patent/TWI284124B/zh not_active IP Right Cessation
- 2003-11-27 PL PL377464A patent/PL377464A1/pl not_active Application Discontinuation
- 2003-11-27 CA CA002508315A patent/CA2508315A1/en not_active Abandoned
- 2003-11-27 BR BR0316962-6A patent/BR0316962A/pt not_active IP Right Cessation
- 2003-11-27 CN CN2003801040190A patent/CN1713908B/zh not_active Expired - Fee Related
- 2003-11-27 NZ NZ539950A patent/NZ539950A/en unknown
- 2003-11-27 KR KR1020057010127A patent/KR100755580B1/ko not_active Expired - Fee Related
- 2003-11-27 HR HR20050457A patent/HRP20050457A2/hr not_active Application Discontinuation
- 2003-11-27 DE DE60316180T patent/DE60316180T2/de not_active Expired - Lifetime
- 2003-11-27 EP EP03782240A patent/EP1569638B1/en not_active Expired - Lifetime
- 2003-11-27 MX MXPA05005790A patent/MXPA05005790A/es active IP Right Grant
- 2003-11-27 AT AT03782240T patent/ATE372113T1/de not_active IP Right Cessation
- 2003-11-27 JP JP2004556206A patent/JP4339795B2/ja not_active Expired - Fee Related
- 2003-11-27 ES ES03782240T patent/ES2291722T3/es not_active Expired - Lifetime
- 2003-11-27 RU RU2005121125/04A patent/RU2350602C2/ru not_active IP Right Cessation
- 2003-11-27 AU AU2003289903A patent/AU2003289903B2/en not_active Ceased
- 2003-11-27 WO PCT/EP2003/013372 patent/WO2004050085A1/en not_active Ceased
- 2003-11-28 PA PA20038589801A patent/PA8589801A1/es unknown
- 2003-11-28 PE PE2003001211A patent/PE20040763A1/es not_active Application Discontinuation
- 2003-12-01 AR ARP030104414A patent/AR042155A1/es unknown
- 2003-12-01 US US10/724,683 patent/US7084169B2/en not_active Expired - Fee Related
- 2003-12-02 MY MYPI20034589A patent/MY138466A/en unknown
2005
- 2005-05-30 ZA ZA200504412A patent/ZA200504412B/en unknown
- 2005-06-07 NO NO20052730A patent/NO20052730L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
MY138466A (en)	2009-06-30
ATE372113T1 (de)	2007-09-15
EP1569638B1 (en)	2007-09-05
ES2291722T3 (es)	2008-03-01
KR100755580B1 (ko)	2007-09-06
US20040132799A1 (en)	2004-07-08
DE60316180D1 (de)	2007-10-18
HRP20050457A2 (en)	2005-10-31
CN1713908B (zh)	2010-05-12
RU2350602C2 (ru)	2009-03-27
JP4339795B2 (ja)	2009-10-07
TW200413312A (en)	2004-08-01
BR0316962A (pt)	2005-10-25
DE60316180T2 (de)	2008-05-29
NZ539950A (en)	2007-05-31
TWI284124B (en)	2007-07-21
NO20052730L (no)	2005-08-23
PL377464A1 (pl)	2006-02-06
RU2005121125A (ru)	2006-02-20
AU2003289903B2 (en)	2008-06-26
ZA200504412B (en)	2006-04-26
CN1713908A (zh)	2005-12-28
PA8589801A1 (es)	2004-11-26
EP1569638A1 (en)	2005-09-07
JP2006509777A (ja)	2006-03-23
WO2004050085A1 (en)	2004-06-17
US7084169B2 (en)	2006-08-01
AR042155A1 (es)	2005-06-08
CA2508315A1 (en)	2004-06-17
PE20040763A1 (es)	2004-11-20
KR20050084155A (ko)	2005-08-26
MXPA05005790A (es)	2005-10-18
AU2003289903A1 (en)	2004-06-23

Publication	Publication Date	Title
NO20052730D0 (no)	2005-06-07	Aminoalkosyindoler som 5-HT6-reseptorligander for behandling av CNS-lidelser
IL182365A0 (en)	2007-07-24	5-sulfonyl-1-piperidinyl substituted indole derivatives as 5-ht6 receptor antagonists for the treatment of cns disorders
NO20014047D0 (no)	2001-08-20	Monoamin reopptaksinhibitorer for behandling av CNS forstyrrelser
NO20040097L (no)	2004-03-01	Kombinasjoner for behandling av inflammatoriske forstyrrelser
AP2005003283A0 (en)	2005-06-30	Indole derivatives useful for the treatment os diseases
NO20052223D0 (no)	2005-05-06	Tiazolforbindelser for behandling av neurodegenerative forstyrrelser
IS2907B (is)	2014-11-15	Bensó[d]asepínafleiður til að meðhöndla taugakvilla
SE0203713D0 (sv)	2002-12-13	Novel compounds
NO20051337L (no)	2005-05-03	Indol- eller benzimidazolderivater for modulering av ikB-kinase.
SI1833799T1 (sl)	2009-02-28	3-fenil-pirazolni derivati kot modulatorji 5-HT2Aserotoninskega receptorja, koristni za zdravljenje motenj v zvezi z njim
NO20034122L (no)	2003-09-16	Sammensmeltede pyridinderivater for anvendelse som vanilloidreseptorantagonister for behandling av smerte
NO20041386L (no)	2004-05-11	Kombinasjoner for bahandling av immunoinflammatoriske forstyrrelser
DK1440059T3 (da)	2008-07-14	3-azabicyclo(3.1.0)hexanderivater som opioidreceptorantagonister
NO20016246L (no)	2002-03-04	Selektiv iGluR5 reseptorantagonist for behandling av migrene
NO20033417D0 (no)	2003-07-30	Anvendelse av CD23-antagonister for behandling av neoplastiske forstyrrelser
NO20055098D0 (no)	2005-11-01	Anvendelse av 10-hydroksy-10,11-dihydrokarbamazepinderivater for behandling av affektive forstyrrelser
NO20026005L (no)	2002-12-13	Indolderivater nyttige for behandlingen av CNS-forstyrrelser
DK1121356T3 (da)	2003-03-24	3-tetrahydropyridin-4-yl-indoler til behandling af psykotiske lidelser
NO20030127L (no)	2003-01-10	Indolderivater nyttige for behandling av CNS-forstyrrelser
NO20052012L (no)	2005-05-26	Indoler nyttige for behadling av androgen-reseptor relaterte sykdommer
NO20026029L (no)	2002-12-16	Indolderivater nyttige for behandlingen av CNS-forstyrrelser
NO20030717D0 (no)	2003-02-14	Forbindelser for behandling av avhengighetsforstyrrelser
DK1458703T3 (da)	2007-06-11	Isochromanforbindelser til behandling af CNS-lidelser
NO20026028D0 (no)	2002-12-16	Indolderivater nyttige for behandlingen av CNS-forstyrrelser
DK1945206T3 (da)	2013-07-29	Indolderivater som histamin 3-receptorinhibitorer til behandling af kognitive forstyrrelser og søvnforstyrrelser, obesitas og andre CNS-forstyrrelser

Legal Events

Date	Code	Title	Description
2011-05-30	FC2A	Withdrawal, rejection or dismissal of laid open patent application